Computational Exploration of Bhrijraj-derived Phytochemicals as Potential Anti-inflammatory Agents: A Molecular Docking Study with Cyclooxygenase-II Complex

Year : 2024 | Volume : 13 | Issue : 01 | Page : 31 37
    By

    Dr. Bhavesh L Dodiya,

  • Janaki H Chauhan,

  • Renish M. Ghetiya,

  1. Head of Department, Department of chemistry, Shri R. R. Lalan College, Bhuj, Gujarat, India
  2. Research Scholar, Department of chemistry, Shri R. R. Lalan College, Bhuj, Gujarat, India
  3. Assistant Professor, , Department of chemistry, Shri K. V. Parekh Science, Matushri T. K. Parekh Arts & smt. G. S. Parekh Commerce College- Mahuva, Gujarat, India

Abstract

The molecular docking analysis was meticulously conducted using state-of-the-art computational tools, notably Chimera and Python. These tools were employed to unravel the complex interactions between the identified phytochemicals from Bhrijraj and the target protein, COX-II. The 3D structures of the phytochemicals were prepared with precision using ChemSketch, ensuring accuracy in the subsequent molecular docking simulations. This rigorous approach enhances the reliability and validity of the findings. This research aims to elucidate the binding affinities of the Bhrijraj-derived phytochemicals to the COX-II complex, shedding light on potential active candidates with anti-inflammatory properties. By understanding the molecular basis of these interactions, novel therapeutic avenues may be explored for the development of more effective anti-inflammatory drugs. The findings of this study not only contribute to our understanding of the molecular mechanisms underlying inflammation but also hold promise for the development of innovative therapeutics in the realm of anti-inflammatory drug discovery. Ultimately, this research bridges the gap between traditional herbal medicine and modern computational techniques, providing valuable insights into the potential pharmacological applications of natural compounds in treating inflammatory conditions. Such interdisciplinary approaches pave the way for the development of safer and more efficacious therapeutic interventions, addressing the growing need for novel anti-inflammatory agents in clinical practice. The objective of this research is to employ molecular docking techniques to explore the interactions between potential drug compounds and target proteins and to identify novel therapeutic agents for the treatment of a specific disease

Keywords: Eclipta prostrata, Molecular Docking, Drug Candidates, ADMET Analysis, Phytochemicals, Medicinal Plants, Binding Affinity, Drug Targets, Pharmacokinetics, Toxicology

[This article belongs to Research & Reviews : Journal of Computational Biology ]

How to cite this article:
Dr. Bhavesh L Dodiya, Janaki H Chauhan, Renish M. Ghetiya. Computational Exploration of Bhrijraj-derived Phytochemicals as Potential Anti-inflammatory Agents: A Molecular Docking Study with Cyclooxygenase-II Complex. Research & Reviews : Journal of Computational Biology. 2024; 13(01):31-37.
How to cite this URL:
Dr. Bhavesh L Dodiya, Janaki H Chauhan, Renish M. Ghetiya. Computational Exploration of Bhrijraj-derived Phytochemicals as Potential Anti-inflammatory Agents: A Molecular Docking Study with Cyclooxygenase-II Complex. Research & Reviews : Journal of Computational Biology. 2024; 13(01):31-37. Available from: https://journals.stmjournals.com/rrjocb/article=2024/view=150323


Browse Figures

References

  1. Karthikumar S, Vigneswari K, et al. Screening of antibacterial and antioxidant activities of leaves of Eclipta prostrata (L.). Sci Res Essays. 2007;2:183–7.
  2. Arunachalam G, Subramanian N, et al. Anti-inflammatory activity of methanolic extract of Eclipta prostrata L. (Astearaceae). Afr J Biotechnol. 2009;8:1122–5.
  3. Feng L, Zhai YY, Xu J, Yao WF, Cao YD, Cheng FF, Bao BH, Zhang L. A review on traditional uses, phytochemistry, and pharmacology of Eclipta prostrata (L.) L. J Ethnopharmacol. 2019;245:112109. DOI: 10.1016/j.jep.2019.112109.
  4. Rahman MS, Rashid MA. Antimicrobial activity and cytotoxicity of Eclipta prostrata. Orient Pharm Exp Med. 2008;8:47–52. DOI: 10.3742/OPEM.2008.8.1.047.
  5. Han L, Liu E, Kojo A, Zhao J, Li W, Zhang Y, Wang T, Gao X. Qualitative and quantitative analysis of Eclipta prostrata L. by LC/MS. Sci World J. 2015;2015:980890. DOI: 10.1155/2015/980890.
  6. Liu QM, Zhao HY, Zhong XK, Jiang JG. Eclipta prostrata L. phytochemicals: Isolation, structure elucidation, and their antitumor activity. Food Chem Toxicol. 2012;50:4016–22. DOI: 10.1016/j.fct.2012.08.007.
  7. Timalsina D, Devkota HP. Eclipta prostrata (L.) L. (Asteraceae): Ethnomedicinal Uses, Chemical Constituents, and Biological Activities. Biomolecules. 2021;11:251.
  8. Chung IM, Rajakumar G, Lee JH, Kim SH, Thiruvengadam M. Ethnopharmacological uses, phytochemistry, biological activities, and biotechnological applications of Eclipta prostrata. Appl Microbiol Biotechnol. 2017;101:5247–57. DOI: 10.1007/s00253-017-8363-9.
  9. Rahman MS, Rahman MZ, Begum B, et al. Antidiabetic principle from Eclipta prostrata. Lat Am J Pharm. 2011;30:255–8.
  10. Karthikumar S, Jegatheesan K, et al. Immunomodulatory activity of Eclipta prostrata. J Med Plants Res. 2011;5:5576–80.
  11. Rajakumar G, Rahuman AA, Priyamvada B, Khanna VG, Kumar DK, Sujin PJ. Eclipta prostrata leaf aqueous extract mediated synthesis of titanium dioxide nanoparticles. Mater Lett. 2012;68:115–7. DOI: 10.1016/j.matlet.2011.10.038.
  12. Pukumpuang W, Chansakaow S, Tragoolpua Y. Antioxidant activity, phenolic compound content and phytochemical constituents of Eclipta prostrata (Linn.) Linn. Chiang Mai J Sci. 2014;41:
    347–56.
  13. Rajakumar G, Abdul Rahuman AA. Larvicidal activity of synthesized silver nanoparticles using Eclipta prostrata leaf extract against filariasis and malaria vectors. Acta Trop. 2011;118:196–203. DOI: 10.1016/j.actatropica.2011.03.003.
  14. Chan CF, Huang WY, Guo HY, Wang BR. Potent antioxidative and UVB protective effect of water extract of Eclipta prostrata L. TheScientificWorldJournal. 2014;2014:759039. DOI: 10.1155/2014/759039.
  15. Liao MY, Chuang CY, Hsieh MJ, Chou YE, Lin CW, Chen WR, Lai CT, Chen MK, Yang SF. Antimetastatic effects of Eclipta prostrata extract on oral cancer cells. Environ Toxicol. 2018;33:923–30. DOI: 10.1002/tox.22577.
  16. Lee MK, Ha NR, Yang H, Sung SH, Kim GH, Kim YC. Antiproliferative activity of triterpenoids from Eclipta prostrata on hepatic stellate cells. Phytomedicine. 2008;15:775–80. DOI: 10.1016/j.phymed.2007.10.004.
  17. Rao DB, Kiran CR, Madhavi Y, Rao PK, Rao TR. Evaluation of the antioxidant potential of Clitoria ternata L. and Eclipta prostrata L. NOPR: Res Articles. 2009;8:249–55.
  18. Chung IM, Abdul Rahuman A, Marimuthu S, Kirthi AV, Anbarasan K, Padmini P, Rajakumar G. Green synthesis of copper nanoparticles using Eclipta prostrata leaves extract and their antioxidant and cytotoxic activities. Exp Ther Med. 2017;14:18–24. DOI: 10.3892/etm.2017.4466.
  19. Altom JV, Murray DS. Factors affecting Eclipta (Eclipta prostrata) seed germination. Weed Technol. 1996;10:727–31. DOI: 10.1017/S0890037X00040720.
  20. Lirdprapamongkol K, Kramb JP, Chokchaichamnankit D, Srisomsap C, Surarit R, Sila-Asna M, Bunyaratvej A, Dannhardt G, Svasti J. Juice of Eclipta prostrata inhibits cell migration in vitro and exhibits anti-angiogenic activity in vivo. In Vivo. 2008;22:363–8.
  21. Lin XH, Wu YB, Lin S, Zeng JW, Zeng PY, Wu JZ. Effects of volatile components and ethanolic extract from Eclipta prostrata on proliferation and differentiation of primary osteoblasts. Molecules. 2010;15:241–50. DOI: 10.3390/molecules15010241.
  22. Chang KM, Kim GH. Constituents of the Essential Oil from Eclipta prostrata L. Prev Nutr Food Sci. 2009;14:168–71. DOI: 10.3746/jfn.2009.14.2.168.
  23. Tewtrakul S, Subhadhirasakul S, Tansakul P, Cheenpracha S, Karalai C. Antiinflammatory constituents from Eclipta prostrata using RAW264.7 macrophage cells. Phytother Res. 2011;25:1313–6. DOI: 10.1002/ptr.3383.
  24. Pithayanukul P, Laovachirasuwan S, Bavovada R, Pakmanee N, Suttisri R. Anti-venom potential of butanolic extract of Eclipta prostrata against Malayan pit viper venom. J Ethnopharmacol. 2004;90:347–52. DOI: 10.1016/j.jep.2003.10.014.
  25. Tewtrakul S, Subhadhirasakul S, Cheenpracha S, Karalai C. HIV-1 protease and HIV-1 integrase inhibitory substances from Eclipta prostrata. Phytother Res. 2007;21:1092–5. DOI: 10.1002/ptr.2252.
  26. Sinha S, Raghuwanshi R. Phytochemical screening and antioxidant potential of Eclipta prostrata (L.) LA valuable herb. Int J Pharm Sci. 2016;8:137–40.
  27. Zhang JS, Guo QM. [Studies on the chemical constituents of Eclipta prostrata (L)]. Yao Xue Xue Bao. 2001 Jan;36(1):34–7. Chinese. PMID: 12579857.
  28. Schutte BJ, Davis AS, Renner KA, Cardina J. Maternal and Burial Environment Effects on Seed Mortality of Velvetleaf (Abutilon theophrasti) and Giant Foxtail (Setaria faberi). Weed Sci. 2008;56:834–40. DOI: 10.1614/WS-08-031.1.
  29. Hossain MS, Alam MB, Chowdhury NS, Asadujjama M, Zahan R, Islam MM, Mazumder MEH, Haque ME, Islam A. Antioxidant, analgesic and anti-inflammatory activities of the herb Eclipta prostrata. J Pharmacol Toxicol. 2011;6:468–80. DOI: 10.3923/jpt.2011.468.480.
Regular Issue Subscription Original Research
Volume 13
Issue 01
Received 22/02/2024
Accepted 05/03/2024
Published 02/04/2024
411

Login


My IP

PlumX Metrics